During the past decade, Hopital du Saint-Sacrement - Quebec conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 36 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 20 clinical trials were completed. i.e. 181.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital du Saint-Sacrement - Quebec" #1 sponsor was "NCIC Clinical Trials Group" with 20 trials, followed by "Hoffmann-La Roche" with 19 trials sponsored, "NSABP Foundation Inc" with 15 trials sponsored, "CHU de Quebec-Universite Laval" with 9 trials sponsored and "National Cancer Institute (NCI)" with 9 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital du Saint-Sacrement - Quebec" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "North Central Cancer Treatment Group" with 7 trials as a collaborator and "Eastern Cooperative Oncology Group" with 6 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Hopital du Saint-Sacrement - Quebec" are "Breast Cancer" (42 trials), "Lymphoma" (7 trials), "Breast Neoplasms" (3 trials), "Colorectal Cancer" (3 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "Hopital du Saint-Sacrement - Quebec" in a lesser frequency.

Most popular intervention types in "Hopital du Saint-Sacrement - Quebec" are "Drug" (81 trials), "Other" (22 trials), "Biological" (17 trials), "Procedure" (16 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "cyclophosphamide" (10 trials), "Cyclophosphamide" (9 trials), "Docetaxel" (9 trials) and "Trastuzumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Hopital du Saint-Sacrement - Quebec" are 61 trials for "All" genders and 45 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital du Saint-Sacrement - Quebec". undefined are not yet recruiting, 11 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Hopital du Saint-Sacrement - Quebec, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital du Saint-Sacrement - Quebec, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".